StepStone Group related stories
All articles and analysis
CPPIB and KKR will invest in German publisher Axel SpringerCanada Pension Plan Investment Board alongside KKR will acquire a stake in Axel Springer, a German publishing firm. CPPIB's financial commitment will be at least 500 million euros.
Side Letter: Wellcome Trusts in VC, secondaries mega-sales, StepStone eyes HNWIsThree global institutional investors including ADIA are eyeing secondaries sales that could total $10 billion – a sign that a mega-sales phase is upon us again. Here’s today's brief, for our valued subscribers only.
StepStone eyes HNWIs with private wealth pushThe firm will integrate fund investments, secondaries and co-investments to create customised investments for the private wealth sector via its Conversus platform.
- StepStone Group launches Conversus
StepStone Group, a private markets specialist, has formed Conversus, a private wealth solutions platform. Bob Long is serving as CEO of Conversus.
UK PE market braces for more uncertainty post no-deal BrexitCapital raising, deal financing and talent retention will face more challenges, according to panellists at a private equity conference in London.
- StepStone appoints Hart as co-CEO
StepStone Group, a private markets specialist, has appointed Scott Hart as co-CEO. Hart joined StepStone in 2007 after working at Morgan Stanley and TPG Capital.
How Arizona PSPRS plans to overhaul its portfolioThe pension system is combining alternative assets into one pool and will re-assess all GP relationships, trimming for better strategic partnerships.
- DWS-led investor group supports Snapdragon and Maze Group's investment in Nutraceutical
A DWS Group-led investor group that includes Blackstone Strategic Partners and StepStone Group, has provided financing to back Snapdragon Capital Partners’ and The Maze Group’s investment in Nutraceutical International Corp. No financial terms were disclosed. Nutraceutical is a provider of branded nutritional supplements, personal care and other natural products. Nutraceutical is backed by HGGC.
American Capital spinout holds first close on Fund IIThe vehicle, which is targeting $375m, is Northlane Capital’s first as an independent manager.
